31st Dec 2008 10:01
For immediate release 31 December 2008 ABCAM PLC ("Abcam" or "the Company") Annual Report and Accounts Abcam plc (AIM: ABC) announces that the Company's Annual Report and Accounts for the year ended 30 June 2008 has been posted to shareholders and may also be viewed on, or downloaded from, the Company's website www.abcam.com. For further information please contact: Abcam + 44 (0) 1223 696000 Jeff Iliffe, Chief Financial Officer Buchanan Communications + 44 (0) 20 7466 5000 Mark Court / Mary-Jane Johnson Numis Securities + 44 (0) 20 7260 1000 Nick Westlake (Nominated Adviser) Notes for editors:
About Abcam plc
Abcam is a producer and distributor of research-grade antibodies headquartered in Cambridge, UK, with a US office located in Cambridge, Massachusetts and a Japanese office in Tokyo. Abcam was admitted to AIM in November 2005 and trades under the ticker symbol ABC. The Company produces and distributes its own and third party produced antibodies to academic and commercial users throughout the world with product information provided and ordering available through the Company's website, www.abcam.com. The antibodies are sold under the Abcam brand name. The Company's vision is to build the largest online antibody resource in the world while also ensuring that the antibodies are of high quality and commercially viable. Abcam now has an online catalogue of over 47,000 products, most of which are antibodies, from over 250 suppliers supported by up-to-date and detailed technical data sheets, which are created by the Company. The Company currently employs over 200 staff in its three operating companies.
Related Shares:
ABC.L